Embolism clinical trials

The registry lists 104 studies for Embolism across more than 10 countries. 14 are recruiting or about to start. 26 of them are mainly about Embolism (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-23. Counting its narrower condition Pulmonary Embolism too: 919 studies, 184 open.

Get an email when these change. Save the Embolism studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 63
Status unknown: 14
Recruiting: 9
Terminated: 8
Not yet recruiting: 5
Active, not recruiting: 3

Phase

Phase 3: 13
Phase 4: 10
Phase 2: 7
Phase 1: 5

Where

United States: 28
France: 19
Germany: 15
Canada: 14
Spain: 12
Denmark: 11

Who runs them

Bayer (11) · Assistance Publique - Hôpitaux de Paris (3) · Stryker Neurovascular (3) · University Hospital, Caen (2) · Daiichi Sankyo Co., Ltd. (2) · ARCA Biopharma, Inc. (2) · Sahlgrenska University Hospital (2) · Sanofi (2)

What is being tested here

Drugs under test in Embolism studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Rivaroxaban	2	1	8
Edoxaban	0	3	3
Warfarin	0	0	3
Tissue Plasminogen Activator	0	0	2
Alfimeprase	0	2	2
Direct Oral Anticoagulant	0	1	1
Apixaban	0	0	1
Rondaptivon pegol sodium	0	0	1
Dalteparin	0	0	1
Certoparin	0	1	1

Drug classes tested here Factor Xa inhibitors 2 open · Thrombolytics 5

Coming up

1phase 3 study under way

7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Dec 2026qDSA Blood Flow Measurement in Patients Undergoing TAE of the Liver · University of Wisconsin, Madison
Dec 2026Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis · Tongji Hospital
Apr 2027Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism Risk · Assistance Publique - Hôpitaux de Paris
Jun 2027A PMCF Study Confirm the Performance and Safety of the TufTex Over-the-Wire (OTW) Embolectomy Catheters · LeMaitre Vascular
Jun 2027RDW and RV-PA Coupling in Acute PE · Assiut University
Aug 2027Translational Immunodiagnostics in Stroke (TrImS) · The University of Hong Kong
Oct 2027What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? · St. Antonius Hospital

Who these studies take

Of the 9 Embolism studies recruiting now, 7 (78%) set no upper age limit and 0 (0%) stop at 75 or younger. 2 (22%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (11%) take healthy volunteers.

Recruiting studies that take each age, of 9
Age	Women	Men
10	2 (22%)	2 (22%)
18	9 (100%)	9 (100%)
30	9 (100%)	9 (100%)
40	9 (100%)	9 (100%)
50	9 (100%)	9 (100%)
65	9 (100%)	9 (100%)
75	9 (100%)	9 (100%)
85	8 (89%)	8 (89%)

Across all 104 studies, recruiting or not: 14% stop at 75 or younger and 9% at 65; 13% take children; 2% are for women only and 3% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Embolism studies take

Of 15 interventional studies with no phase under Embolism, half reached primary completion within 19 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Interventional, no phase	19 mo17–66 · 15 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 104. Browse all 104 → or search them.